Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial.
about
Sentinel Lymph Node in Breast Cancer: Review Article from a Pathologist's Point of ViewManagement of Axilla in 2015 in Indian ScenarioAxillary treatment for operable primary breast cancer.Utility of sentinel lymph node biopsy for solitary dermal melanomas.Sentinel node mapping for breast cancer: current situationSentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis.Local treatment of the axilla in early breast cancer: concepts from the national surgical adjuvant breast and bowel project B-04 to the planned intergroup sentinel mamma trialRelationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32.Investigation of lipid composition of dissected sentinel lymph nodes of breast cancer patients by 7T proton MR spectroscopy.Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trialComparison of three magnetic nanoparticle tracers for sentinel lymph node biopsy in an in vivo porcine modelHow many sentinel lymph nodes are enough for accurate axillary staging in t1-2 breast cancer?Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis.A grid matrix-based Raman spectroscopic method to characterize different cell milieu in biopsied axillary sentinel lymph nodes of breast cancer patients.The feasibility of the ACOSOG Z0011 Criteria to Chinese Breast Cancer Patients: A Multicenter Study.Breast cancer: from "maximum tolerable" to "minimum effective" treatmentBreast cancer recurrence after sentinel lymph node biopsy.What is the future of axillary surgery for breast cancer?The Role of Blue Dye in Sentinel Node Detection for Breast Cancer: A Retrospective Study of 203 Patients.A 10-year trend analysis of sentinel lymph node frozen section and completion axillary dissection for breast cancer: are these procedures becoming obsolete?Impact of sentinel node biopsy on long-term quality of life in breast cancer patients.Technetium-99m-labeled rituximab for use as a specific tracer of sentinel lymph node biopsy: a translational research studyPrognostic value of nodal ratios in node-positive breast cancer: a compiled update.Endoscopic nipple sparing mastectomy with immediate implant-based reconstruction versus breast conserving surgery: a long-term study.Surgeon specialization and use of sentinel lymph node biopsy for breast cancer.Tubular breast carcinoma: an argument against treatment de-escalation.Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care.Sentinel lymph node biopsy in primary breast cancer: window to management of the axilla.Magnetic sentinel lymph node biopsy and localization properties of a magnetic tracer in an in vivo porcine model.Is imaging the future of axillary staging in breast cancer?Relevance of the American College of Surgeons Oncology Group Z0011 Trial to breast cancer in the Australian setting.Blue dye is sufficient for sentinel lymph node biopsy in breast cancer.Meta-analysis of superficial versus deep injection of radioactive tracer and blue dye for lymphatic mapping and detection of sentinel lymph nodes in breast cancer.Macrometastasis, micrometastasis, and isolated tumor cells in sentinel lymph nodes of early breast cancers: a 10-year histopathological and survival analysis of 537 Asian patients.Superparamagnetic iron oxide nanoparticles for MR imaging of pancreatic cancer: Potential for early diagnosis through targeted strategies.Surgeon knows best versus breast cancer surgical clinical trial equipoise: a plea for the sake of future trials.Meta-analysis of aberrant lymphatic drainage in recurrent breast cancer.Is SLN Biopsy Alone Safe in SLN Positive Breast Cancer Patients?
P2860
Q26772240-3D8122CA-3BAE-4BA3-A93A-F48F6C8CAC3AQ28079495-0E121FEB-2364-48ED-87E1-2BAB019DC520Q30239832-853FB1AD-8669-4FA3-BA22-9EF6C62154CDQ30358585-E91CF6D4-C911-4713-9A51-0197A82606D2Q30464471-A05BA44D-A7F6-4701-9587-30F2F43795F3Q31022615-B68920B7-6D39-4DC6-B8A0-DEFA07B209CBQ33684856-7EC8E8F7-0D11-4C33-8587-E6F9DB860147Q34039923-EBB5A504-58A0-4C51-B520-049532C6379FQ34040176-3DCCB242-4EE0-4417-A5E9-0970ADC5C1F9Q34127272-E658BA06-78C8-44B7-B8FE-87DE1B9B0C3BQ34131757-F274BED8-2644-462F-AB5D-1CDE655ACE14Q34139672-F7A34AA4-7043-49F4-9134-767EF38C747AQ35101000-06C7A9F5-F6D8-48BC-9436-4482445AF7F4Q35713840-00C8A769-BA02-4FBF-88BC-73B157995D27Q35832380-4FB3AAF6-E7AA-4D76-B7FC-786E33F95832Q35836589-6F58A395-47EB-4ABC-8590-428D34E486FFQ36168193-0790F847-EAC6-4D2B-BAE2-C424C6FA4999Q36302102-B613C41B-E860-4223-94EC-3D924027A487Q36552933-BEC8363D-4E40-4741-996F-0A7385EB1358Q36863202-BCAC375C-BA39-4E89-832C-CBC28F90DA75Q36938358-103CE4F4-DF9E-4084-A283-FAD7ECF2E952Q37210899-C87D1A97-FD7E-4924-A6EA-D8BE71549703Q37352592-3E8AD3BF-0FE0-4CEF-96CD-DC882A3D7B60Q37437666-1A883E29-A5FC-4A52-8917-F03DE25FD988Q37650599-42BE1771-2DE1-4C9B-826D-C0CEE6080643Q37731446-7188658C-414F-411C-BFC6-37995B276750Q37733754-E24B793B-A3AA-46D5-90C2-47B2A2271583Q37984641-E85AA217-9B88-48AB-8A06-9440E7FDD503Q38001373-89EA02D9-06CC-4625-964F-AE8E6D647FDAQ38007324-DD698C5D-14A2-43F7-B6F4-A1AB3567406CQ38129715-102AC56C-8366-47DC-A368-D9ABD5B2E340Q38137722-46AE7A30-FDC8-4221-979D-9C058904A0D9Q38167328-31EDA859-30D9-4E75-A635-A4ED3BB74096Q38184924-FF4A188D-4250-4ED9-97DF-78B3E476D249Q38289626-799B5AA1-BA57-4C01-A863-40A0E99EBD4CQ38344288-4A93324A-AACE-4589-B34F-68C367F63530Q38668514-CCD257B1-1E91-42A6-A765-F10EC23B164CQ38751470-19F0CACC-9469-4088-BA21-2B8562D44B0BQ38947019-9D4056ED-8094-40AF-91FE-6DF93AE1FBC9Q38961720-5E8530C5-EBD5-4C78-9910-EFB878053F63
P2860
Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Sentinel-lymph-node-based mana ...... zed controlled surgical trial.
@en
Sentinel-lymph-node-based mana ...... opsy versus axillary clearance
@nl
type
label
Sentinel-lymph-node-based mana ...... zed controlled surgical trial.
@en
Sentinel-lymph-node-based mana ...... opsy versus axillary clearance
@nl
prefLabel
Sentinel-lymph-node-based mana ...... zed controlled surgical trial.
@en
Sentinel-lymph-node-based mana ...... opsy versus axillary clearance
@nl
P1476
Sentinel-lymph-node-based mana ...... zed controlled surgical trial.
@en
P2093
Grantley Gill
SNAC Trial Group of the Royal ...... d NHMRC Clinical Trials Centre
P2888
P304
P356
10.1245/S10434-008-0229-Z
P577
2008-12-03T00:00:00Z
P6179
1046341250